INSERM, U708, Hôpital de la Salpêtrière, Paris, France.
J Hypertens. 2010 Jul;28(7):1506-14. doi: 10.1097/HJH.0b013e328338bbec.
The brain is one of the main targets of hypertension. However, little is known about the relation between hypertension and motor performances. We studied the association between hypertension and walking speed in a cohort of elderly people.
Analyses are based on participants (65-85 years) from the Dijon (France) center of the Three-City study (n = 3604), followed every 2 years. Persistent hypertension was defined by the use of antihypertensive drugs at baseline or at first follow-up, or by high blood pressure (> or =140/90 mmHg) at baseline and first follow-up. Walking speed was measured over 6 m, at baseline and fourth follow-up (n = 1774) after a mean (SD) duration of 7.0 (0.5) years. Brain MRI was performed in 1590 participants. Generalized linear models were used to assess the relation between hypertension and baseline walking speed or walking speed change.
At baseline, mean (SD) walking speed (m/s) was lower in hypertensive patients [1.51 (0.31)] than in nonhypertensive individuals [1.59 (0.30), P < 0.001]. During follow-up, hypertensive patients had a higher mean annual decline in walking speed [cm/s per year; 2.30 (3.4)] than nonhypertensive individuals [1.87 (3.3), P = 0.004]. The number of antihypertensive drugs was associated with lower walking speed at baseline and higher walking speed decline. Adjustment for MRI white matter abnormalities attenuated these relations.
Persistent hypertension was associated with both lower walking speed and higher decline in walking speed in the elderly. These results may be partly explained by white matter abnormalities and support the hypothesis of a contribution of vascular risk factors to motor dysfunction.
大脑是高血压的主要靶器官之一。然而,人们对高血压与运动表现之间的关系知之甚少。我们研究了高血压与老年人步行速度之间的关系。
分析基于来自第戎(法国)的三城市研究中心的参与者(65-85 岁)(n=3604),每 2 年随访一次。持续性高血压的定义为基线或首次随访时使用抗高血压药物,或基线和首次随访时血压高(>或=140/90mmHg)。在平均(SD)7.0(0.5)年的时间后,在基线和第四次随访(n=1774)时测量 6m 内的步行速度。在 1590 名参与者中进行了脑部 MRI。使用广义线性模型评估高血压与基线步行速度或步行速度变化之间的关系。
在基线时,高血压患者的平均(SD)步行速度(m/s)[1.51(0.31)]低于非高血压患者[1.59(0.30),P<0.001]。在随访期间,高血压患者的步行速度年均下降幅度更高[cm/s/年;2.30(3.4)],而非高血压患者的步行速度年均下降幅度更高[1.87(3.3),P=0.004]。抗高血压药物的数量与基线时的步行速度较低和步行速度下降幅度较高有关。调整 MRI 白质异常后,这些关系减弱。
持续性高血压与老年人的步行速度较低和步行速度下降幅度较高有关。这些结果部分可能是由白质异常引起的,并支持血管危险因素对运动功能障碍有贡献的假设。